EoE patients on the biologic drug dupilumab in a Phase 3 trial showed significant symptom improvement by six months of… Read more »
Tag: Cincinnati Children’s Hospital Medical Center
Cell Discovery May Answer Who’s at Risk of Severe Allergic Reaction
A cell that produces an inflammatory immune protein may amplify anaphylaxis.